Vladimir A. Tolmachev

Uppsala, C 75185, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 227 publications

Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide.

Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide.

Journal: International journal of molecular sciences

Published: July 01, 2026

Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 08, 2026

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 27, 2026

Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.

Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.

Journal: Molecular pharmaceutics

Published: May 14, 2026

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

Journal: Molecular pharmaceutics

Published: March 04, 2026

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 15, 2026

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal: Journal of biological engineering

Published: January 13, 2026

Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Journal: International journal of molecular sciences

Published: December 29, 2025

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Journal: International journal of biological macromolecules

Published: November 13, 2025

Design of 3D spheroid models for drug-response studies of HER2-targeted radiopharmaceuticals.

Design of 3D spheroid models for drug-response studies of HER2-targeted radiopharmaceuticals.

Journal: Biomaterials advances

Published: September 14, 2025

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 04, 2025

Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Journal: International journal of molecular sciences

Published: August 28, 2025

Showing 1-12 of 227

Last Updated: 09/26/2026